References
Surgeon General. Reducing the health consequences of smoking. US Dept of Health and Human Services, 1989
Glantz SA, Parmley WW. Circulation 83: 1–12, 1991
West RJ. J Psychosom Res 28: 379–386, 1984
Roost C, Hines E. VA Practitioner 9: 41–46, Nov 1992
Palmer KJ, et al. Drugs 44: 498–529, 1992
Schneider N. Clin Pharmacokinet 23: 169–172, 1992
Hurt RD, et al. Mayo Clin Proc 65: 1529–1537, 1990
Rose JE, et al. Clin Pharmacol Ther 38: 450–456, 1985
Fagerström K-O, et al. J Smoking-Related Dis 2: 173–180, 1991
Buchkremer G, et al. Addict Behav 14: 229–238, 1989
Buchkremer G, et al. Pharmacopsychiatry 24: 96–102, 1991
Rose JE, et al. Clin Pharmacol Ther 47: 323–330, 1990
Tønnesen P, et al. N Engl J Med 325: 311–315, 1991
Transdermal Nicotine Study Group. JAMA 266: 3133–3138, 1991
Hwang SL, Waldholt M. Wall Street Journal: B1, June 19, 1992
Benowitz NL, et al. Biomed Pharmacother 43: 1–3, 1989
Gourlay SG, McNeil JJ. Med J Aust 153: 699–707, 1990
British National Formulary 24: 198 & xii, 1992
New Ethicals Catalogue: 360, Dec 1992
Rights and permissions
About this article
Cite this article
Transdermal Nicotine: High Relapse Rate Limits Success in Nicotine Withdrawal. Drugs Ther. Perspect 1, 1–4 (1993). https://doi.org/10.2165/00042310-199301050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199301050-00001